title: Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebral venous thrombosis 1 month after resumption of the medication at the age of 50.
authors: D
authors: D
authors: Tormene
authors: P
authors: P
authors: Simioni
authors: M T
authors: MT
authors: Sartori
authors: A
authors: A
authors: Girolami
mesh_terms: D002550:Cerebral Veins; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006579:Heterozygote; D006801:Humans; D020767:Intracranial Thrombosis / Q000209:etiology*; D008875:Middle Aged; D009154:Mutation; D011247:Pregnancy; D011516:Prothrombin / Q000235:genetics*
chemical_list: D003276:Contraceptives, Oral; D011516:Prothrombin